Search Results 751-760 of 16561 for alopecia

  1. DHEA - Mayo Clinic

    Dehydroepiandrosterone (DHEA) is a hormone that your body naturally produces in the adrenal gland. DHEA helps produce other hormones, including testosterone ...

  2. A Study of TNB-383B in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Alopecia;; Peripheral neuropathy (peripheral neuropathy ≥ Grade 3 will be excluded);; Anemia or thrombocytopenia (the latter cytopenias must be Grade 4 to ...

  3. Weight loss The Mayo Clinic Diet

    Need to lose weight? Skip the fad diets. Go for healthy eating and exercise habits. It's the smart way to take weight off and keep it off.

  4. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...

  5. Our Research - Neural Regenerative Research - Mayo Clinic Research

    The Neural Regenerative Research Lab of Alexander Y. Shin, M.D., at Mayo Clinic studies peripheral motor nerve regeneration of nerve autografts and ...

  6. A Study to Evaluate the Use of Confocal Laser Endomicroscopy as an IMaging Biomarker (CLIMB Study) for the Diagnosis of Pancreatic Cystic Lesions - Mayo Clinic

    The purpose of this study is to evaluate EUS-nCLE as an imaging biomarker and PCL fluid DNA analysis as a molecular biomarker for the management of pancreatic ...

  7. Biomarkers in Autoimmune and Inflammatory Diseases - Mayo Clinic

    The purpose of this study is to identify biomarkers in people with autoimmune or inflammatory disease and in healthy people. We will use these biomarkers to ...

  8. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

    Patients who have not recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities > Grade 1) with the exception of alopecia.

  9. Publications - Carrie A. Thompson, M.D. - Mayo Clinic

    Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directions. Crit Rev Oncol Hematol. 2020 Dec; 156:103093. Epub 2020 Sep ...

  10. About CAR-T cell therapy - Mayo Clinic

    Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...